1 over slow holiday weekend 4:26p Stock-market rally depends on answer to this ‘real question’ about bond yields 3:51p Biden strikes hopeful tone, urges Americans to ‘keep the faith’ for better days ahead 3:40p A final look at how the U.S. stock market performed under Joe Biden ...
BioNTech's stock slides 3.4% after earnings fall short amid shrinking COVID vaccine sales Aug. 5, 2024 at 7:16 a.m. ETby Ciara Linnane New U.S. bird-flu case is first with respiratory symptoms, CDC says May. 30, 2024 at 2:52 p.m. ETby Eleanor Laise ...
BNTX Stock USD 113.95 0.18 0.16% Our overall analysis of BioNTech's news coverage and content from conventional and social sources shows investors' bearish mood towards BioNTech SE. The specific impact of BioNTech news on its stock price will depend on a range of factors, including the nature...
Additional Tools for BioNTech Stock Analysis When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to ...
Cash reserves are growing, while stock is bought back. We recommend placing a stop-loss at $78, looking to achieve $137 -- upside potential of 31%. Yield 0% (Analysts’ price target is $137.07) Pharma & Healthcare The Panic-Proof Portfolio (Stockchase Research) $103.845 Unknown ...
*Stock Advisor returns as of November 4, 2024 We undertake no obligation to update or revise any of these statements. On Slide 3, you can find the agenda for today's call. Today, I am joined by the following members of Biotech's management team: Uğur Şahin, chief executive officer...
In another report released on December 9, Morgan Stanley also maintained a Buy rating on the stock with a $145.00 price target. See Insiders’ Hot Stocks on TipRanks >> TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timin...
Analyst John Newman of Canaccord Genuity maintained a Buy rating on BioNTech SE (BNTX – Research Report), retaining the price target of $171.00. Jo...
BioNTech SE Sponsored ADR(BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $141.61 ...
On the morning of Nov. 20, shares of Germany-based biotechnology companyBioNTech SE(NASDAQ:BNTX) are pushing higher on heavy volume. Further, the BNTX stock price is smashing through the $100 barrier. What’s all the fuss about?